Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Tóm tắt
Từ khóa
Tài liệu tham khảo
Adams, 1978, Quantitative analysis of ketamine enantiomers, Proc West Pharmacol Soc, 21, 471
Andrade, 2017, Ketamine for depression, 3: does chirality matter?, J Clin Psychiatry, 78, e674, 10.4088/JCP.17f11681
Andrade, 2017, Ketamine for depression, 4: in what dose, at what rate, by what route, for how long, and at what frequency?, J Clin Psychiatry, 78, e852
Azevedo, 2000, Transdermal ketamine as an adjuvant for postoperative analgesia after abdominal gynecological surgery using lidocaine epidural blockade, Anesth Analg, 91, 1479, 10.1097/00000539-200012000-00034
Azzaro, 1977, The inhibitory action of ketamine HC1 on [3H]5-hydroxytryptamine accumulation by rat brain synaptosomal-rich fractions: comparison with [3H]catecholamine and [3H]γ-aminobutyric acid uptake, Neuropharmacology, 16, 349, 10.1016/0028-3908(77)90072-7
Ballard, 2017, Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials, J Affect Disord, 218, 195, 10.1016/j.jad.2017.04.057
Benoit, 1995, Effects of intravenous anaesthetics on nerve axons, Eur J Anaesthesiol, 12, 59
Bion, 1984, Intrathecal ketamine for war surgery: a preliminary study under field conditions, Anaesthesia, 39, 1023, 10.1111/j.1365-2044.1984.tb08895.x
Bolze, 1998, HPLC determination of ketamine, norketamine, and dehydronorketamine in plasma with a high-purity reversed-phase sorbent, Clin Chem, 44, 560, 10.1093/clinchem/44.3.560
Bonifazi, 2015, Novel potent N-methyl-d-aspartate (NMDA) receptor antagonists or σ1 receptor ligands based on properly substituted 1,4-dioxane ring, J Med Chem, 58, 8601, 10.1021/acs.jmedchem.5b01214
Bree, 1967, Safety and tolerance of repeated anesthesia with CI 581 (ketamine) in monkeys, Anesth Analg, 46, 596
Canuso CM Singh JB Fedgchin M Alphs L Lane R Lim P Pinter C Hough D Sanacora G Manji H (2018) Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study. Am J Psychiatry DOI: 10.1176/appi.ajp.2018.17060720.
Cavalleri, 2017, Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling, Molecular Psychiatry, 23, 812, 10.1038/mp.2017.241
Chang, 1974, Biotransformation and disposition of ketamine, Int Anesthesiol Clin, 12, 157, 10.1097/00004311-197412020-00018
Chen, 1966, The neuropharmacology of 2-(omicron-chlorophenyl)-2-methylaminocyclohexanoe hydrochloride, J Pharmacol Exp Ther, 152, 332
Cheng, 2007, GC-MS quantification of ketamine, norketamine, and dehydronorketamine in urine specimens and comparative study using ELISA as the preliminary test methodology, J Chromatogr B Analyt Technol Biomed Life Sci, 852, 443, 10.1016/j.jchromb.2007.02.005
Cusin, 2017, Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation, Aust N Z J Psychiatry, 51, 55, 10.1177/0004867416631828
Daly, 2018, Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial, JAMA Psychiatry, 75, 139, 10.1001/jamapsychiatry.2017.3739
De Felice, 2017, Monoamine transporters as ionotropic receptors, Trends Neurosci, 40, 195, 10.1016/j.tins.2017.02.003
Delini-Stula A (1980) Drug-induced alterations in animal behavior as a tool for the evaluation of antidepressants: correlation with biochemical effects, in Psychotropic Agents: Part I: Antipsychotics and Antidepressants ( Hoffmeister F Stille G eds) pp 505–526, Springer, Berlin.
Dinis-Oliveira, 2017, Metabolism and metabolomics of ketamine: a toxicological approach, Forensic Sci Res, 2, 2, 10.1080/20961790.2017.1285219
Domino, 2010, Taming the ketamine tiger: 1965, Anesthesiology, 113, 678, 10.1097/ALN.0b013e3181ed09a2
Downey, 2016, Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate, Eur Neuropsychopharmacol, 26, 994, 10.1016/j.euroneuro.2016.03.006
du Jardin, 2016, Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression, Psychopharmacology (Berl), 233, 2813, 10.1007/s00213-016-4327-5
Dundee, 1970, Ketamine as an induction agent in anaesthetics, Lancet, 1, 1370, 10.1016/S0140-6736(70)91273-0
Dundee, 1978, Ketamine-iorazepam: attenuation of psychic sequelae of ketamine by lorazepam, Anaesthesia, 33, 312, 10.1111/j.1365-2044.1978.tb12413.x
Emnett, 2016, A clickable analogue of ketamine retains NMDA receptor activity, psychoactivity, and accumulates in neurons, Sci Rep, 6, 38808, 10.1038/srep38808
Erdemir, 1970, Dissociative anesthesia with ketamine: a suitable adjunct to epidural anesthesia, Anesth Analg, 49, 623, 10.1213/00000539-197007000-00025
Fanta, 2015, Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing, Eur J Clin Pharmacol, 71, 441, 10.1007/s00228-015-1826-y
Flood, 2000, Intravenous anesthetics differentially modulate ligand-gated ion channels, Anesthesiology, 92, 1418, 10.1097/00000542-200005000-00033
Fukumoto, 2014, Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test, Psychopharmacology (Berl), 231, 2291, 10.1007/s00213-013-3378-0
Gage, 1985, Prolongation of inhibitory postsynaptic currents by pentobarbitone, halothane and ketamine in CA1 pyramidal cells in rat hippocampus, Br J Pharmacol, 85, 675, 10.1111/j.1476-5381.1985.tb10563.x
Gao, 2016, Ketamine use in current clinical practice, Acta Pharmacol Sin, 37, 865, 10.1038/aps.2016.5
Georg, 1991, Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma × rat glioma hybrid cell line NG108-15, J Pharmacol Exp Ther, 259, 479
George, 2017, Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression, Am J Geriatr Psychiatry, 25, 1199, 10.1016/j.jagp.2017.06.007
Ghoneim, 1985, Ketamine: behavioral effects of subanesthetic doses, J Clin Psychopharmacol, 5, 70, 10.1097/00004714-198504000-00003
Gill, 2000, Ketamine in non-hospital and hospital deaths in New York city, J Forensic Sci, 45, 655, 10.1520/JFS14742J
Goldberg, 2010, Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome, Pain Physician, 13, 379, 10.36076/ppj.2010/13/379
Gómez de Segura, 1998, Epidural injection of ketamine for perineal analgesia in the horse, Vet Surg, 27, 384, 10.1111/j.1532-950X.1998.tb00145.x
Gorlin, 2016, Intravenous sub-anesthetic ketamine for perioperative analgesia, J Anaesthesiol Clin Pharmacol, 32, 160, 10.4103/0970-9185.182085
Gould, 2017, Animal models to improve our understanding and treatment of suicidal behavior, Transl Psychiatry, 7, e1092, 10.1038/tp.2017.50
Grott Zanicotti, 2013, Case report: long-term mood response to repeat dose intramuscular ketamine in a depressed patient with advanced cancer, J Palliat Med, 16, 719, 10.1089/jpm.2013.0057
Haas, 1992, Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia, Anesth Prog, 39, 61
Hance, 1989, Catalepsy induced by combinations of ketamine and morphine: potentiation, antagonism, tolerance and cross-tolerance in the rat, Neuropharmacology, 28, 109, 10.1016/0028-3908(89)90045-2
Hare BD Ghosal S Duman RS (2017) Rapid acting antidepressants in chronic stress models: molecular and cellular mechanisms. Chronic Stress (Thousand Oaks) 1: DOI: 10.1177/2470547017697317.
Hargreaves, 1994, Neuroprotective NMDA antagonists: the controversy over their potential for adverse effects on cortical neuronal morphology, Acta Neurochir Suppl (Wien), 60, 15
Harris, 1975, Attention, learning, and personality during ketamine emergence: a pilot study, Anesth Analg, 54, 169, 10.1213/00000539-197503000-00001
Hashimoto, 2014, Blood D-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine, Psychopharmacology (Berl), 231, 4081, 10.1007/s00213-014-3735-7
Hawksworth, 1998, Intrathecal anesthesia with ketamine, Reg Anesth Pain Med, 23, 283
Hennein, 1994, Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization, J Thorac Cardiovasc Surg, 108, 626, 10.1016/S0022-5223(94)70286-1
Hirlinger, 1984, Intramuscular ketamine analgesia in emergency patients. II. Clinical study of traumatized patients, Anaesthesist, 33, 272
Hirsiger, 2012, Danger signals activating the immune response after trauma, Mediators Inflamm, 2012, 315941, 10.1155/2012/315941
Ho, 2004, Single amino acid residue in the extracellular portion of transmembrane segment 2 in the nicotinic alpha7 acetylcholine receptor modulates sensitivity to ketamine, Anesthesiology, 100, 657, 10.1097/00000542-200403000-00028
Hornik CP Gonzalez D van den Anker J Atz AM Yogev R Poindexter BB Ng KC Delmore P Harper BL Melloni C (2018) Population pharmacokinetics of intramuscular and intravenous ketamine in children. J Clin Pharmacol 54: DOI: 10.1002/jcph.1116.
Hu, 2016, Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study, Psychol Med, 46, 623, 10.1017/S0033291715002159
Huang, 2009, Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer’s disease, J Alzheimers Dis, 16, 15, 10.3233/JAD-2009-0960
Ihmsen, 2001, Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine, Clin Pharmacol Ther, 70, 431, 10.1067/mcp.2001.119722
Ionescu, 2015, A single infusion of ketamine improves depression scores in patients with anxious bipolar depression, Bipolar Disord, 17, 438, 10.1111/bdi.12277
Jozwiak, 2002, Displacement and nonlinear chromatographic techniques in the investigation of interaction of noncompetitive inhibitors with an immobilized alpha3beta4 nicotinic acetylcholine receptor liquid chromatographic stationary phase, Anal Chem, 74, 4618, 10.1021/ac0202029
Kadriu B Gold PW Luckenbaugh DA Lener MS Ballard ED Niciu MJ Henter ID Park LT De Sousa RT Yuan P (2017) Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder. Mol Psychiatry [published ahead of print].
Kang, 2017, Ephenidine: a new psychoactive agent with ketamine-like NMDA receptor antagonist properties, Neuropharmacology, 112, 144, 10.1016/j.neuropharm.2016.08.004
Karch SB Drummer OH (2015) Dissociative anesthetics, in Karch’s Pathology of Drug Abuse, 5th ed, pp 697–754, CRS Press, Boca Raton, FL.
Kathirvel, 2000, Effects of intrathecal ketamine added to bupivacaine for spinal anaesthesia, Anaesthesia, 55, 899, 10.1046/j.1365-2044.2000.01472.x
Ke, 2018, The profile of cognitive impairments in chronic ketamine users, Psychiatry Res, 266, 124, 10.1016/j.psychres.2018.05.050
Kokkinou, 2018, The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders, Mol Psychiatry, 23, 59, 10.1038/mp.2017.190
Kortekaas, 2008, Despite irreversible binding, PET tracer [11C]-SA5845 is suitable for imaging of drug competition at sigma receptors: the cases of ketamine and haloperidol, Neurochem Int, 53, 45, 10.1016/j.neuint.2008.04.010
Krystal, 2001, Comment on “ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D(2) receptor.”, Biol Psychiatry, 50, 555, 10.1016/S0006-3223(01)01258-6
Lai, 2014, Pilot dose-response trial of i.v. ketamine in treatment-resistant depression, World J Biol Psychiatry, 15, 579, 10.3109/15622975.2014.922697
Lepack AE Fuchikami M Dwyer JM Banasr M Duman RS (2014) BDNF release is required for the behavioral actions of ketamine. Int J Neuropsychopharmacol 18: DOI: 10.1093/ijnp/pyu033.
Li, 2016, The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: a randomized controlled study, Hum Brain Mapp, 37, 1080, 10.1002/hbm.23085
Li, 1997, Ketamine inhibits nitric oxide synthase in lipopolysaccharide-treated rat alveolar macrophages, Can J Anaesth, 44, 989, 10.1007/BF03011971
Li, 2014, Inhibition of HCN1 channels by ketamine accounts for its antidepressant actions, Sichuan Da Xue Xue Bao Yi Xue Ban, 45, 888
Li, 2017, Chronic ketamine exposure causes white matter microstructural abnormalities in adolescent cynomolgus monkeys, Front Neurosci, 11, 285, 10.3389/fnins.2017.00285
Lilius, 2018, Ketamine and norketamine attenuate oxycodone tolerance markedly less than that of morphine: from behaviour to drug availability, Br J Anaesth, 120, 818, 10.1016/j.bja.2017.11.081
Lilius, 2018, Interactions of (2S,6S;2R,6R)-Hydroxynorketamine, a Secondary Metabolite of (R,S)-Ketamine, with Morphine, Basic Clin Pharmacol Toxicol, 122, 481, 10.1111/bcpt.12941
Lim, 2003, Ketamine associated psychedelic effects and dependence, Singapore Med J, 44, 31
Lin, 1992, General anesthetics potentiate gamma-aminobutyric acid actions on gamma-aminobutyric acidA receptors expressed by Xenopus oocytes: lack of involvement of intracellular calcium, J Pharmacol Exp Ther, 263, 569
Lisek, 2016, Regional brain dysregulation of Ca(2+)-handling systems in ketamine-induced rat model of experimental psychosis, Cell Tissue Res, 363, 609, 10.1007/s00441-015-2332-3
Little, 1972, Study of ketamine as an obstetric anesthetic agent, Am J Obstet Gynecol, 113, 247, 10.1016/0002-9378(72)90774-0
Lockhart, 1974, The relationship of ketamine requirement to age in pediatric patients, Anesthesiology, 40, 507, 10.1097/00000542-197405000-00020
Loix, 2011, The anti-inflammatory effects of ketamine: state of the art, Acta Anaesthesiol Belg, 62, 47
Loo, 2016, Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression, Acta Psychiatr Scand, 134, 48, 10.1111/acps.12572
Lynch, 1995, Pharmacological characterization of heterodimeric NMDA receptors composed of NR 1a and 2B subunits: differences with receptors formed from NR 1a and 2A, J Neurochem, 64, 1462, 10.1046/j.1471-4159.1995.64041462.x
Ma, 2017, Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamine, Psychopharmacology (Berl), 234, 3165, 10.1007/s00213-017-4700-z
MacDonald, 1987, Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine, J Neurophysiol, 58, 251, 10.1152/jn.1987.58.2.251
Malaquin, 1984, Ketamine via rectal route for the induction of pediatric anesthesia, Cah Anesthesiol, 32, 373
Marchetti, 2015, Efficacy and safety of oral ketamine for the relief of intractable chronic pain: a retrospective 5-year study of 51 patients, Eur J Pain, 19, 984, 10.1002/ejp.624
Marietta, 1977, On the pharmacology of the ketamine enantiomorphs in the rat, J Pharmacol Exp Ther, 202, 157
Martin, 1988, Inhibition of synaptosomal serotonin uptake by Ketalar, Res Commun Chem Pathol Pharmacol, 62, 129
Martin, 1982, Ketamine inhibits serotonin uptake in vivo, Neuropharmacology, 21, 113, 10.1016/0028-3908(82)90149-6
Meng, 2013, A murderer of young bladders: ketamine-associated cystitis, Urol Sci, 24, 113, 10.1016/j.urols.2013.09.001
Moaddel, 2015, D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression, Psychopharmacology (Berl), 232, 399, 10.1007/s00213-014-3669-0
Moaddel, 2015, The distribution and clearance of (2S,6S)-hydroxynorketamine, an active ketamine metabolite, in Wistar rats, Pharmacol Res Perspect, 3, e00157, 10.1002/prp2.157
Morgan, 2006, Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users, Biol Psychiatry, 59, 265, 10.1016/j.biopsych.2005.06.018
Morris, 2017, Synthesis and N-methyl-d-aspartate (NMDA) receptor activity of ketamine metabolites, Org Lett, 19, 4572, 10.1021/acs.orglett.7b02177
Newton K Dixit VM (2012) Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 4: DOI: 10.1101/cshperspect.a006049.
Oye, 1992, Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors, J Pharmacol Exp Ther, 260, 1209
Pacheco Dda, 2014, Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors, Brain Res, 1562, 69, 10.1016/j.brainres.2014.03.026
Pande, 1999, A placebo-controlled trial of igmesine in the treatment of major depression, Eur Neuropsychopharmacol, 9, 138, 10.1016/S0924-977X(99)80011-X
Park, 2017, Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression, J Psychiatr Res, 84, 113, 10.1016/j.jpsychires.2016.09.025
Peltoniemi, 2016, Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy, Clin Pharmacokinet, 55, 1059, 10.1007/s40262-016-0383-6
Peltoniemi, 2012, Rifampicin has a profound effect on the pharmacokinetics of oral S-ketamine and less on intravenous S-ketamine, Basic Clin Pharmacol Toxicol, 111, 325, 10.1111/j.1742-7843.2012.00908.x
Petrenko, 2014, Defining the role of NMDA receptors in anesthesia: are we there yet?, Eur J Pharmacol, 723, 29, 10.1016/j.ejphar.2013.11.039
Pham TH Defaix C Xu X Deng SX Fabresse N Alvarez JC Landry DW Brachman RA Denny CA Gardier AM (2017 a) Common neurotransmission recruited in (R,S)-ketamine and (2R,6R)-hydroxynorketamine-induced sustained antidepressant-like effects. Biol Psychiatry [published ahead of print].
Pham, 2017, Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice, Neuropharmacology, 112, 198, 10.1016/j.neuropharm.2016.05.010
Porter, 1995, Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential, J Neurochem, 64, 614, 10.1046/j.1471-4159.1995.64020614.x
Rao, 2016, Role of cytochrome P4502B6 polymorphisms in ketamine metabolism and clearance, Anesthesiology, 125, 1103, 10.1097/ALN.0000000000001392
Reynolds, 1989, Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines, Mol Pharmacol, 36, 758
Riva-Posse P Reiff CM Edwards JA Job GP Galendez GC Garlow SJ Saah TC Dunlop BW McDonald WM (2018) Blood pressure safety of subanesthetic ketamine for depression: a report on 684 infusions. J Affect Disord DOI: 10.1016/j.jad.2018.02.025 [published ahead of print].
Rosa, 2016, Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors, Pharmacol Rep, 68, 996, 10.1016/j.pharep.2016.05.010
Roytblat, 1993, Postoperative pain: the effect of low-dose ketamine in addition to general anesthesia, Anesth Analg, 77, 1161, 10.1213/00000539-199312000-00014
Russabrov, 2008, Effect of ketamine on inflammatory and immune responses after short- duration surgery in obese patients, Open Anesthesiol J, 2, 40, 10.2174/1874321800802010040
Selye, 1976, Forty years of stress research: principal remaining problems and misconceptions, Can Med Assoc J, 115, 53
Shimada, 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians, J Pharmacol Exp Ther, 270, 414
Shirayama, 2018, Lack of antidepressant effects of (2R,6R)-hydroxynorketamine in a rat learned helplessness model: comparison with (R)-ketamine, Int J Neuropsychopharmacol, 21, 84, 10.1093/ijnp/pyx108
Short, 2018, Side-effects associated with ketamine use in depression: a systematic review, Lancet Psychiatry, 5, 65, 10.1016/S2215-0366(17)30272-9
Siegel, 1978, Phencyclidine and ketamine intoxication: a study of four populations of recreational users, NIDA Res Monogr, 21, 119
Singh NS Bernier M Camandola S Khadeer MA Moaddel R Mattson MP Wainer IW (2015) Enantioselective inhibition of d-serine transport by (S)-ketamine. Br J Pharmacol DOI: 10.1111/bph.13239 [published ahead of print].
Singh, 2013, Nicotinic acetylcholine receptor antagonists alter the function and expression of serine racemase in PC-12 and 1321N1 cells, Cell Signal, 25, 2634, 10.1016/j.cellsig.2013.08.025
Singh, 2016, Ketamine metabolites enantioselectively decrease intracellular D-serine concentrations in PC-12 cells, PLoS One, 11, e0149499, 10.1371/journal.pone.0149499
Singh, 2014, What is hydroxynorketamine and what can it bring to neurotherapeutics?, Expert Rev Neurother, 14, 1239, 10.1586/14737175.2014.971760
Sofia, 1975, Evaluation of ketamine HCl for anti-depressant activity, Arch Int Pharmacodyn Ther, 214, 68
Stewart, 2001, Ketamine as a street drug, Emerg Med Serv, 30, 30, 32, 34 passim
Suzuki, 2017, Effects of a ketamine metabolite on synaptic NMDAR function, Nature, 546, E1, 10.1038/nature22084
Szymkowicz, 2013, A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression, J Affect Disord, 147, 416, 10.1016/j.jad.2012.10.015
Takeyama, 2006, Ketamine enhances the expression of serine racemase and D-amino acid oxidase mRNAs in rat brain, Eur J Pharmacol, 540, 82, 10.1016/j.ejphar.2006.04.021
Tanaka, 2000, Reevaluation of rectal ketamine premedication in children: comparison with rectal midazolam, Anesthesiology, 93, 1217, 10.1097/00000542-200011000-00014
Temme, 2018, Comparative pharmacological study of common NMDA receptor open channel blockers regarding their affinity and functional activity toward GluN2A and GluN2B NMDA receptors, ChemMedChem, 13, 446, 10.1002/cmdc.201700810
Traber, 1969, Involvement of the sympathetic nervous system in the pressor response to ketamine, Anesth Analg, 48, 248, 10.1213/00000539-196903000-00020
Traber, 1970, The effect of beta-adrenergic blockade on the cardiopulmonary response to ketamine, Anesth Analg, 49, 604
Vickers, 2017, A case report: subanesthetic ketamine infusion for treatment of cancer-related pain produces urinary urge incontinence, A A Case Rep, 8, 219, 10.1213/XAA.0000000000000472
Vyklicky, 2014, Structure, function, and pharmacology of NMDA receptor channels, Physiol Res, 63, S191, 10.33549/physiolres.932678
Wallach, 2016, Pharmacological investigations of the dissociative ‘legal highs’ diphenidine, methoxphenidine and analogues, PLoS One, 11, e0157021, 10.1371/journal.pone.0157021
Wan, 2015, Ketamine safety and tolerability in clinical trials for treatment-resistant depression, J Clin Psychiatry, 76, 247, 10.4088/JCP.13m08852
Wang, 2013, Brain damages in ketamine addicts as revealed by magnetic resonance imaging, Front Neuroanat, 7, 23, 10.3389/fnana.2013.00023
Wang, 2007, Novel sigma (sigma) receptor agonists produce antidepressant-like effects in mice, Eur Neuropsychopharmacol, 17, 708, 10.1016/j.euroneuro.2007.02.007
Watanabe, 2010, Subchronic administration of ketamine decreases the mRNA expression of serine racemase in rat brain, Tokai J Exp Clin Med, 35, 137
Wei, 2017, Acute amino acid d-serine administration, similar to ketamine, produces antidepressant-like effects through identical mechanisms, J Agric Food Chem, 65, 10792, 10.1021/acs.jafc.7b04217
Weisman, 1971, Anesthesia for pediatric ophthalmology, Ann Ophthalmol, 3, 229
Wieber, 1975, Pharmacokinetics of ketamine in man, Anaesthesist, 24, 260
Wilkins, 2012, Anomalous bodily-self experiences among recreational ketamine users, Cogn Neuropsychiatry, 17, 415, 10.1080/13546805.2012.663162
Wohleb, 2017, Molecular and cellular mechanisms of rapid-acting antidepressants ketamine and scopolamine, Curr Neuropharmacol, 15, 11, 10.2174/1570159X14666160309114549
Woolf, 1987, Biotransformation of ketamine, (Z)-6-hydroxyketamine, and (E)-6-hydroxyketamine by rat, rabbit, and human liver microsomal preparations, Xenobiotica, 17, 839, 10.3109/00498258709043993
Wray NH Schappi JM Singh H Senese NB Rasenick MM (2018) NMDAR-independent, cAMP-dependent antidepressant actions of ketamine. Mol Psychiatry DOI: 10.1038/s41380-018-0083-8 [published ahead of print].
Wu, 1996, Pharmacological characterization of inward current evoked by N-methyl-D-aspartate in dopamine neurons in the rat brain slice, J Pharmacol Exp Ther, 279, 457
Yamamoto, 2013, Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys, Neuropsychopharmacology, 38, 2666, 10.1038/npp.2013.176
Yamazaki, 1992, Effects of ketamine on voltage-dependent Ca2+ currents in single smooth muscle cells from rabbit portal vein, Pharmacology, 45, 162, 10.1159/000138994
Yanagihara, 2001, Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes, Drug Metab Dispos, 29, 887
Yang, 2016, Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine, Psychiatry Res, 239, 281, 10.1016/j.psychres.2016.03.034
Yang, 2017, (R)-Ketamine shows greater potency and longer lasting antidepressant effects than its metabolite (2R,6R)-hydroxynorketamine, Biol Psychiatry, 82, e43, 10.1016/j.biopsych.2016.12.020
Yang, 2005, Large dose ketamine inhibits lipopolysaccharide-induced acute lung injury in rats, Inflamm Res, 54, 133, 10.1007/s00011-004-1334-5
Yao N Skiteva O Zhang X Svenningsson P Chergui K (2017) Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit. Mol Psychiatry DOI: 10.1038/mp.2017.239 [published ahead of print].
Zanos, 2018, Intracellular signaling pathways involved in (S)- and (R)-ketamine antidepressant actions, Biol Psychiatry, 83, 2, 10.1016/j.biopsych.2017.10.026
Zanos, 2018, Convergent mechanisms underlying rapid antidepressant action, CNS Drugs, 32, 197, 10.1007/s40263-018-0492-x
Zanos, 2018, Mechanisms of ketamine action as an antidepressant, Mol Psychiatry, 23, 801, 10.1038/mp.2017.255
Zanos P Moaddel R Morris PJ Georgiou P Fischell J Elmer GI Alkondon M Yuan P Pribut HJ Singh NS (2017 a) Zanos et al. reply. Nature DOI: 10.1038/nature22085.
Zanos, 2017, Reply to: antidepressant actions of ketamine versus hydroxynorketamine, Biol Psychiatry, 81, e69, 10.1016/j.biopsych.2016.08.039
Zhang, 2018, Other drug use does not impact cognitive impairments in chronic ketamine users, Drug Alcohol Depend, 186, 1, 10.1016/j.drugalcdep.2018.01.007